Table of Contents

Global Cancer Supportive Care Drugs Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Cancer Supportive Care Drugs Market Size 2014-2024
  • 2.1.2 Cancer Supportive Care Drugs Market Size CAGR by Region
• 2.2 Cancer Supportive Care Drugs Segment by Type
  • 2.2.1 G-CSFs (Granulocyte-colony Stimulating Factors)
  • 2.2.2 G-CSFs (Granulocyte-colony Stimulating Factors)
  • 2.2.3 Anti-emetics
  • 2.2.4 Bisphosphonates
  • 2.2.5 Opioids
  • 2.2.6 NSAIDs
• 2.3 Cancer Supportive Care Drugs Market Size by Type
  • 2.3.1 Global Cancer Supportive Care Drugs Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (2014-2019)
• 2.4 Cancer Supportive Care Drugs Segment by Application
  • 2.4.1 Chemotherapy Therapy
  • 2.4.2 Radiation Therapy
• 2.5 Cancer Supportive Care Drugs Market Size by Application
  • 2.5.1 Global Cancer Supportive Care Drugs Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Cancer Supportive Care Drugs Market Size Growth Rate by Application (2014-2019)

3 Global Cancer Supportive Care Drugs by Players

• 3.1 Global Cancer Supportive Care Drugs Market Size Market Share by Players
  • 3.1.1 Global Cancer Supportive Care Drugs Market Size by Players (2017-2019)
  • 3.1.2 Global Cancer Supportive Care Drugs Market Size Market Share by Players (2017-2019)
• 3.2 Global Cancer Supportive Care Drugs Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Cancer Supportive Care Drugs by Regions

• 4.1 Cancer Supportive Care Drugs Market Size by Regions
• 4.2 Americas Cancer Supportive Care Drugs Market Size Growth
• 4.3 APAC Cancer Supportive Care Drugs Market Size Growth
• 4.4 Europe Cancer Supportive Care Drugs Market Size Growth
• 4.5 Middle East & Africa Cancer Supportive Care Drugs Market Size Growth

5 Americas

• 5.1 Americas Cancer Supportive Care Drugs Market Size by Countries
• 5.2 Americas Cancer Supportive Care Drugs Market Size by Type
• 5.3 Americas Cancer Supportive Care Drugs Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Cancer Supportive Care Drugs Market Size by Countries
• 6.2 APAC Cancer Supportive Care Drugs Market Size by Type
• 6.3 APAC Cancer Supportive Care Drugs Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Cancer Supportive Care Drugs by Countries
• 7.2 Europe Cancer Supportive Care Drugs Market Size by Type
• 7.3 Europe Cancer Supportive Care Drugs Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Cancer Supportive Care Drugs by Countries
• 8.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Type
• 8.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Cancer Supportive Care Drugs Market Forecast

• 10.1 Global Cancer Supportive Care Drugs Market Size Forecast (2019-2024)
• 10.2 Global Cancer Supportive Care Drugs Forecast by Regions
  • 10.2.1 Global Cancer Supportive Care Drugs Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Cancer Supportive Care Drugs Forecast by Type
• 10.8 Global Cancer Supportive Care Drugs Forecast by Application

11 Key Players Analysis

• 11.1 Roche
  • 11.1.1 Company Details
  • 11.1.2 Cancer Supportive Care Drugs Product Offered
  • 11.1.3 Roche Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Roche News
• 11.2 Johnson & Johnson
  • 11.2.1 Company Details
  • 11.2.2 Cancer Supportive Care Drugs Product Offered
  • 11.2.3 Johnson & Johnson Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Johnson & Johnson News
• 11.3 Amgen
  • 11.3.1 Company Details
  • 11.3.2 Cancer Supportive Care Drugs Product Offered
  • 11.3.3 Amgen Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Amgen News
• 11.4 Helsinn Healthcare
  • 11.4.1 Company Details
  • 11.4.2 Cancer Supportive Care Drugs Product Offered
  • 11.4.3 Helsinn Healthcare Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Helsinn Healthcare News
• 11.5 Merck
  • 11.5.1 Company Details
  • 11.5.2 Cancer Supportive Care Drugs Product Offered
  • 11.5.3 Merck Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Merck News
• 11.6 Heron Pharma
  • 11.6.1 Company Details
  • 11.6.2 Cancer Supportive Care Drugs Product Offered
  • 11.6.3 Heron Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Heron Pharma News
• 11.7 Tesaro
  • 11.7.1 Company Details
  • 11.7.2 Cancer Supportive Care Drugs Product Offered
  • 11.7.3 Tesaro Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Tesaro News

...

12 Research Findings and Conclusion

According to this study, over the next five years the Cancer Supportive Care Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cancer Supportive Care Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Cancer Supportive Care Drugs market by product type, application, key companies and key regions.

This study considers the Cancer Supportive Care Drugs value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
G-CSFs (Granulocyte-colony Stimulating Factors)
ESAs (Erythropoiesis Stimulating Agents)
Anti-emetics
Bisphosphonates
Opioids
NSAIDs

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Chemotherapy Therapy
Radiation Therapy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Johnson & Johnson
Amgen
Helsinn Healthcare
Merck
Heron Pharma
Tesaro
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cancer Supportive Care Drugs market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cancer Supportive Care Drugs market by identifying its various subsegments.
Focuses on the key global Cancer Supportive Care Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Supportive Care Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cancer Supportive Care Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.